Discovery of Sovleplenib, a Selective Inhibitor of Syk in Clinical Development for Autoimmune Diseases and Cancers
Sovleplenib 的发现:一种选择性 Syk 抑制剂,目前正处于治疗自身免疫性疾病和癌症的临床开发阶段
期刊:ACS Medicinal Chemistry Letters
影响因子:4
doi:10.1021/acsmedchemlett.3c00553
Jia, Hong; Deng, Wei; Hao, Baoyu; Cai, Min; Guo, Dong; Cai, Yu; Dai, Xiaoming; Wu, Zhipeng; He, Weigang; Wang, Jian; Wang, Guanglin; Xia, Sumei; Li, Na; Su, Weiguo; Dai, Guangxiu